These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37133524)

  • 1. Hydrodynamic characterization of a vesicular stomatitis virus-based oncolytic virus using analytical ultracentrifugation.
    Wawra S; Kessler S; Egel A; Solzin J; Burkert O; Hochdorfer D
    Eur Biophys J; 2023 Jul; 52(4-5):379-386. PubMed ID: 37133524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum.
    Pipperger L; Koske I; Wild N; Müllauer B; Krenn D; Stoiber H; Wollmann G; Kimpel J; von Laer D; Bánki Z
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
    Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants.
    Pipperger L; Riepler L; Kimpel J; Siller A; Stoitzner P; Bánki Z; von Laer D
    Oncoimmunology; 2021; 10(1):1959140. PubMed ID: 34484872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein.
    Stegelmeier AA; Chan L; Mehrani Y; Petrik JJ; Wootton SK; Bridle B; Karimi K
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?
    Zhang Y; Nagalo BM
    Front Immunol; 2022; 13():898631. PubMed ID: 35837384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Therapy of Solid Tumors by Modified Vesicular Stomatitis Virus.
    Gao Y
    DNA Cell Biol; 2024 Feb; 43(2):57-60. PubMed ID: 38079267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute quantification of viral proteins from pseudotyped VSV-GP using UPLC-MRM.
    Basu R; Dambra R; Jiang D; Schätzlein SA; Njiyang S; Ashour J; Chiramel AI; Vigil A; Papov VV
    Microbiol Spectr; 2024 Aug; 12(8):e0365123. PubMed ID: 38916347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP.
    Vijver SV; Danklmaier S; Pipperger L; Gronauer R; Floriani G; Hackl H; Das K; Wollmann G
    Front Immunol; 2022; 13():1100730. PubMed ID: 36741416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector.
    Wollmann G; Paglino JC; Maloney PR; Ahmadi SA; van den Pol AN
    Virology; 2015 Jan; 475():1-14. PubMed ID: 25462341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiomic Profiling Identified EGF Receptor Signaling as a Potential Inhibitor of Type I Interferon Response in Models of Oncolytic Therapy by Vesicular Stomatitis Virus.
    Nikitina AS; Lipatova AV; Goncharov AO; Kliuchnikova AA; Pyatnitskiy MA; Kuznetsova KG; Hamad A; Vorobyev PO; Alekseeva ON; Mahmoud M; Shakiba Y; Anufrieva KS; Arapidi GP; Ivanov MV; Tarasova IA; Gorshkov MV; Chumakov PM; Moshkovskii SA
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Propagation and Quantification of Two Emerging Oncolytic Viruses: Vesicular Stomatitis (VSV) and Zika (ZIKV).
    Means RE; Roy SG; Katz SG
    Methods Mol Biol; 2020; 2097():253-263. PubMed ID: 31776931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus.
    Alkayyal AA; Ajina R; Cacciabue M; Alkayyal AA; Saeedi NH; Hussain Alshehry T; Kaboha F; Alotaibi MA; Zaidan N; Shah K; Alroqi F; Bakur Mahmoud A
    Front Immunol; 2023; 14():1082191. PubMed ID: 36798114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Cycle Arrest in G
    Bressy C; Droby GN; Maldonado BD; Steuerwald N; Grdzelishvili VZ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.
    Velazquez-Salinas L; Naik S; Pauszek SJ; Peng KW; Russell SJ; Rodriguez LL
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):108-115. PubMed ID: 28514874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
    Betancourt D; Ramos JC; Barber GN
    J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIG-I-mediated innate immune signaling in tumors reduces the therapeutic effect of oncolytic vesicular stomatitis virus.
    Zhang P; Han X; Tan W; Chen D; Sun Q
    Thorac Cancer; 2023 Jan; 14(3):246-253. PubMed ID: 36447430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
    Kimpel J; Urbiola C; Koske I; Tober R; Banki Z; Wollmann G; von Laer D
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29498639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4.
    Moon J; Kaowinn S; Cho IR; Min DS; Myung H; Oh S; Kaewpiboon C; Kraemer OH; Chung YH
    Biochem Biophys Res Commun; 2016 Jun; 474(3):428-434. PubMed ID: 27150631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tool with many applications: vesicular stomatitis virus in research and medicine.
    Munis AM; Bentley EM; Takeuchi Y
    Expert Opin Biol Ther; 2020 Oct; 20(10):1187-1201. PubMed ID: 32602788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.